ResMed Inc (RMD) works to increase awareness of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. The company provides diagnoses and develops treatments for these conditions for people worldwide.
Find out what a historical investment in Resmed would be worth today using our RMD stock calculator.
Buying RMD shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Resmed in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in RMD
What is the ticker symbol of Resmed?
The ticker symbol for Resmed is RMD.
How much is one share of RMD?
One share of RMD is valued at $35.41 as of 22 November 2026.
What is the market capitalisation of Resmed RMD?
As of 22 November 2026 Resmed has a market cap of $19.82B.
Does RMD pay dividends?
Yes, RMD does pay dividends.
What is the dividend yield for RMD?
The dividend yield for RMD is 1.02% as of 22 November 2026.
How much dividends does RMD pay?
The most recent RMD dividend distribution paid $0.07 per share on 17 December 2026.
What is the RMD ex-dividend date?
The ex-dividend date of RMD was 11 November 2026.
What is the P/E ratio of RMD?
The Price to Earnings ratio of RMD is 23.34.
What is the Earnings Per Share of RMD?
The Earnings Per Share of RMD is $1.52.
What is the 52-week high for Resmed stock?
The Resmed 52-week high stock price is $39.94.
What is the 52-week low for Resmed stock?
The Resmed 52-week low stock price is $25.50.
Can I buy RMD shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy RMD shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.